Related by context. All words. (Click for frequent words.) 76 Infusion Reactions Severe 74 proctitis 74 hypophosphatemia 74 neutropaenia 73 lopinavir r arm 73 placebo dexamethasone 73 neutropenia dehydration dyspnea 73 ertapenem 73 leucopenia 72 relapsed MM 72 fatigue asthenia 72 gastrointestinal perforation 72 myelodysplastic myeloproliferative diseases 72 deep venous thromboses 72 CIMZIA TM certolizumab pegol 72 hematologic toxicity 72 BARACLUDE ® 72 metastatic GIST 71 invasive candidiasis 71 neutropenia thrombocytopenia 71 transaminase elevations 71 candidemia 71 mcg kg REBETOL 71 lymphopenia 71 myalgia arthralgia 71 febrile neutropenia 71 Postoperative complications 71 HBeAg negative patients 71 recurrent glioblastoma multiforme 71 oxycodone CR 71 hepatic failure 71 invasive aspergillosis 71 Renal impairment 71 Dermatologic toxicities 71 elevated ALT 71 peripheral sensory neuropathy 71 haematologic 71 Stomatitis 71 neutropenia febrile neutropenia 71 â ‰ ¥ 71 imipenem 70 malignant neoplasms 70 arterial thromboembolic events 70 receiving PEGINTRON 70 generalized edema 70 histologic subtype 70 incidence ≥ 70 hemorrhagic cystitis 70 hepatorenal syndrome 70 aldosterone antagonist 70 NMIBC 70 mcg QD 70 methicillin susceptible Staphylococcus aureus 70 mucosal inflammation 70 gastrointestinal toxicities 70 mucocutaneous reactions 70 receiving Vectibix monotherapy 70 metastatic malignant 70 laboratory abnormalities 70 pyrexia mucositis sepsis febrile 70 biologic DMARD 70 recurrent DVT 70 neoplasias 70 receiving VICTRELIS 70 receiving XGEVA 70 oral Hycamtin 70 comparator arm 70 thrombocytopenic 70 malignant neoplasm 70 severe exacerbations 70 HBeAg positive patients 70 HBeAg negative 70 S. aureus isolates 69 papillary renal cell carcinoma 69 Adenomas 69 unresectable HCC 69 achieved ACR# 69 CMV infection 69 headache abdominal pain 69 CTAP# 69 moderately emetogenic 69 sensory neuropathy 69 cutaneous squamous cell carcinoma 69 angioneurotic edema 69 Engerix B 69 Amgen Neulasta R 69 grade cervical intraepithelial 69 included exfoliative dermatitis 69 Erythropoietic therapies may 69 ACTEMRA TM 69 ara C 69 CCyR 69 metastatic neuroendocrine tumors 69 anogenital warts 69 REYATAZ r arm 69 CP CPPS 69 COPD exacerbation 69 postoperative infections 69 TMP SMX 69 plus methotrexate 69 ethambutol 69 gadobutrol 69 neurologic complications 69 severe NCI CTC 69 ARCALYST ® 69 Folfox 69 advanced adenoma 69 ANCA associated 69 biochemical relapse 69 nadroparin 69 myocardial infarction ventricular fibrillation 69 fluconazole resistant 69 nosocomial pneumonia 69 Ribavirin causes 69 ALT flares 69 cervical intraepithelial neoplasia 69 VFEND 69 micafungin 69 LV dysfunction 68 INCB# [003] 68 dermatologic reactions 68 colorectal adenoma 68 renal scarring 68 ARCOXIA 68 acute respiratory tract infections 68 reactogenicity 68 octreotide LAR 68 morphometric vertebral fractures 68 leukopenia 68 chronic GVHD 68 TEAEs 68 bronchoalveolar lavage 68 MYCAMINE 68 mediastinitis 68 DOXIL 68 alemtuzumab treated 68 NNT = 68 severe hypersensitivity reactions 68 endometrial hyperplasia 68 Serious adverse reactions 68 % CI #.#-#.# [007] 68 MCyR 68 precancerous cervical 68 Hematologic 68 treatment naive genotype 68 venous stasis ulcers 68 vWD 68 severe neutropenia 68 smoldering myeloma 68 neutropenic fever 68 Mitomycin C 68 rFVIIa 68 rebleeding 68 vaginal lesions 68 receiving ISENTRESS 68 KRAS mutations occur 68 recurrent metastatic 68 idiopathic PAH 68 psoriatic arthritis PsA 68 FOLFIRI alone 68 non splenectomized 68 plus 5-FU/LV 68 CIN2 + 68 pericardial effusion 68 genitourinary GU 68 cGy 68 microbiological eradication 68 heparin induced thrombocytopenia 68 histological subtype 68 recurrent VTE 68 Zometa hazard 68 Relapsing remitting MS 68 Toxicities 68 CIN3 68 macrolide antibiotic 68 conjunctival hyperemia 68 definite stent thrombosis 68 neutropenic sepsis 68 interferon ribavirin 68 EXJADE 68 % CI #.#-#.# [008] 68 SGPT 68 Intravenous immunoglobulin 68 tazobactam 68 BCG vaccinated 68 evaluable subjects 68 splenectomized 68 piperacillin tazobactam 68 necrotizing pancreatitis 68 tipranavir r 68 external genital lesions 68 abacavir Ziagen 68 pT3 67 hematologic adverse 67 bacterium Neisseria meningitidis 67 Flu Cy 67 salmeterol fluticasone 67 idiopathic thrombocytopenic purpura ITP 67 PREZISTA r arm 67 alpha interferons 67 postoperative infection 67 salmeterol fluticasone propionate 67 anemia leukopenia 67 intracranial hemorrhage ICH 67 hematological adverse 67 hypereosinophilic syndrome 67 symptomatic VTE 67 overt nephropathy 67 receiving VELCADE 67 bronchial hyperresponsiveness 67 Hypotension 67 ug dose 67 intravenous bisphosphonates 67 osteoporotic vertebral compression fractures 67 unstable angina pectoris 67 varicella infection 67 mycophenolate mofetil MMF 67 mitoxantrone plus 67 partial remissions 67 Enterobacter cloacae 67 certolizumab 67 de novo AML 67 prolonged QT interval 67 hematological toxicities 67 Acneform rash occurred 67 Papillary 67 thrombocytopenia neutropenia 67 stomatitis 67 alfa 2a 67 adalimumab Humira 67 Lymphocytic 67 receiving INTRON 67 anterior uveitis 67 trimethoprim sulfamethoxazole 67 INVANZ 67 autoantibody positive 67 erythema nodosum 67 prospectively enrolled 67 INTEGRILIN R 67 locoregional recurrence 67 dalteparin 67 amoxicillin clavulanate 67 cough dyspnea 67 Clostridium difficile infections 67 non metastatic osteosarcoma 67 pericardial effusions 67 Abrupt discontinuation 67 pimecrolimus cream 67 thromboembolic complications 67 myopathy rhabdomyolysis 67 diphtheria pertussis whooping cough 67 cytogenic 67 Bacteremia 67 recurrent venous thromboembolism 67 discontinued Viread 67 immunocompetent patients 67 DAS# CRP 67 heFH 67 hyperphenylalaninemia HPA due 67 TMC# r 67 CANCIDAS 67 autologous SCT 67 Hycamtin ® 67 S. aureus bloodstream infections 67 recurrent genital herpes 67 CYPHER Stent 67 aspartate aminotransferase 67 ribavirin therapy 67 cIAI 67 hypomagnesemia 67 cisplatin gemcitabine 67 enterocolitis 67 liver histology 67 atrophic gastritis 67 ZEVALIN therapeutic regimen 67 Angioedema 67 pegylated interferon alfa 2b 67 del 5q MDS 67 gastroduodenal 67 Sezary syndrome 67 serologic testing 67 neutropenia anemia 67 plus aztreonam 67 Peg IFN 67 chronic eosinophilic leukemia 67 ZYVOX 67 enterococcal 67 ß blockers 67 intra abdominal infections 67 pulmonary dysfunction 67 Mg Usa 67 essential thrombocythemia ET 67 MAGE A3 ASCI 67 Pegasys peginterferon alfa 2a 67 invasive carcinomas 67 QTc prolongation 67 ano genital warts 67 ARIXTRA 67 Naive Patients 67 4mg/kg 67 TNF antagonist 67 squamous histology 67 leukemia AML 67 symptomatic intracranial 67 clodronate 67 onset diabetes mellitus 67 Index CDAI 67 SSc 67 MACCE 67 tamoxifen Nolvadex ® 67 MALT lymphoma 67 anaphylactic reactions bronchospasm 67 dermatologic toxicities 67 severe rotavirus gastroenteritis 67 microbiologically evaluable 67 anemia neutropenia 67 HIV HCV coinfected 67 erosive gastritis 67 #mg BID [001] 67 resistant Staphylococcus aureus MRSA 67 doripenem 67 mcg BID 67 chills fever headache 67 dysplastic lesions 67 bullous 67 Amgen Neulasta ® 67 BSIs 66 vaccinees 66 nicardipine 66 STELARA ™ 66 immuno compromised patients 66 Bloodstream infections 66 benign prostatic hypertrophy BPH 66 BUPHENYL 66 NATRECOR ® 66 skeletal metastases 66 receiving highly emetogenic 66 advanced adenomas 66 ALT elevations 66 basal cell carcinoma BCC 66 vincristine doxorubicin 66 receiving prophylactic anticoagulation 66 Telithromycin 66 C difficile infection 66 Enterococcus faecium 66 prednisone prednisolone plus 66 Gastrointestinal GI 66 CIMZIA ™ 66 corticosteroid therapy 66 Acute Bacterial Sinusitis ABS 66 efalizumab 66 cervical vaginal 66 Pemetrexed 66 nephrotoxicity 66 Myelosuppression 66 mCRC acneform rash 66 decompensated liver disease 66 kidney urologic 66 pancytopenia 66 nonsevere 66 stage IIIb IV 66 P. falciparum malaria 66 nonmelanoma skin cancers 66 TAXUS p value 66 fatigue diarrhea nausea 66 acetonide FA 66 steroid dexamethasone 66 complement inhibitor eculizumab 66 Nebulized 66 salmeterol HFA MDI 66 postoperative chemotherapy 66 cytomegalovirus infection 66 tigecycline 66 anemia hemoglobin 66 Opportunistic infections 66 Glioblastoma Multiforme 66 postoperative complication 66 superficial basal cell carcinoma 66 symptomatic aortic stenosis 66 complete cytogenetic response 66 Febrile neutropenia 66 diarrhea nausea fatigue 66 seropositivity 66 cytogenetic abnormalities 66 HeFH 66 antiretroviral naïve 66 achieved CCyR 66 pulmonary alveolar 66 subependymal giant cell 66 G CSFs 66 carbapenem resistant 66 elevated transaminases 66 hypokalemia 66 PRADAXA #mg 66 pT2 66 aphthous stomatitis 66 oral allopurinol 66 nadolol 66 TYGACIL 66 PREZISTA r 66 epithelial tumors 66 rosuvastatin #mg 66 Interferon beta 1b 66 mycophenolate 66 adjunctive placebo 66 SNT-MC#/idebenone 66 adverse cytogenetics 66 p = NS 66 CLL SLL 66 recurrent UTI 66 alfuzosin 66 dacarbazine DTIC 66 ALT elevation 66 See WARNINGS 66 ximelagatran 66 S aureus 66 HPV-#/# 66 ergot derivatives 66 Peginterferon alfa 2b 66 events SAEs 66 events AEs 66 Kepivance 66 ORENCIA ® 66 chorioamnionitis 66 FOLFOX4 66 vulvovaginal candidiasis 66 grade cervical dysplasia 66 portal vein thrombosis 66 % CI #.#-#.# [003] 66 interstitial pneumonia 66 bronchogenic carcinoma 66 events TEAEs 66 herpes zoster shingles 66 NSTEMI 66 allogeneic HSCT 66 discontinuations due 66 sternal wound infections 66 lymphocytosis 66 Patients Receiving 66 abacavir lamivudine 66 overactive bladder syndrome 66 perioperative mortality 66 posterior uveitis 66 VaD 66 HBeAg seroconversion 66 thromboembolism 66 colorectal carcinoma 66 lupus erythematosus 66 Platinol ® 66 glycated hemoglobin levels 66 thrombophlebitis 66 mg BID dose 66 immune thrombocytopenic purpura ITP 66 REMICADE monotherapy 66 Candida infection 66 renal toxicity 66 idraparinux 66 Squamous 66 HBV infections 66 mycophenolate mofetil 66 NEUPOGEN 66 chronic urticaria 66 sirolimus stent 66 CALGB # [002] 66 follicular lymphoma FL 66 systemic corticosteroid 66 monoinfected patients 66 5-FU/LV 66 underwent resection 66 metastatic carcinoid tumors 66 AST ALT 66 histologically confirmed 66 Moxifloxacin 66 Known hypersensitivity 66 S. aureus infections 66 treatment naïve genotype 66 Staphylococcus aureus infections 66 pharyngitis tonsillitis 66 post transplant lymphoproliferative 66 % AST SGOT 66 esophageal candidiasis 66 esophagitis 66 neutropenic patients 66 Severe cutaneous 66 Warfarin Coumadin 66 simplex virus 65 headache nasopharyngitis 65 mg/m2 dose 65 Neutropenia 65 superficial edema 65 cytopenias 65 cerebrovascular accidents 65 venous thromboembolic disease 65 voriconazole 65 hematologic abnormalities 65 NATRECOR R 65 pamidronate 65 elevated LDH 65 QTcF 65 8mg/kg 65 acneform rash 65 Escherichia coli Klebsiella pneumoniae 65 mild renal insufficiency 65 p# biomarker 65 alanine aminotransferase 65 Teriflunomide 65 deletion 5q 65 oropharyngeal candidiasis OPC 65 HBeAg 65 SPRYCEL ® 65 Virologic 65 Cariprazine 65 thalidomide Thalomid 65 genotype 1b 65 somatostatin analog 65 thromboembolic events 65 cidofovir 65 GOUT 65 upper gastrointestinal bleeding 65 infective endocarditis 65 atrioventricular block 65 lenalidomide Revlimid R 65 bacteraemia 65 MIC# [001] 65 peritoneal cancer 65 Fludara ® 65 Catheter Associated 65 pruritus rash 65 pegylated interferon alfa 65 acromegalic patients 65 oral diclofenac 65 venous blood clots 65 Thrombocytopenia 65 MetroGel 65 antiemetics 65 prednisone prednisolone 65 COPD exacerbations 65 chronic immune thrombocytopenic 65 Unstable Angina 65 orchitis 65 Chronic lymphocytic leukemia 65 transfusion syndrome 65 parasitemia 65 susceptible isolates 65 alanine aminotransferase ALT 65 adverse reactions occurring 65 Tumor Response 65 ritonavir boosted 65 gross hematuria 65 leiomyomas 65 graft dysfunction 65 cystic fibrosis chronic pancreatitis 65 gonococcal 65 XIENCE V PROMUS Stent 65 PSA nadir 65 inflammatory acne 65 cerebrovascular events 65 patients evaluable 65 severe oral mucositis 65 metabolic alkalosis 65 vapreotide acetate 65 CTAP# Capsules 65 total thyroidectomy 65 nosocomial pneumonia NP 65 sulfamethoxazole 65 hypertrichosis occurred 65 caspofungin 65 genotypic resistance 65 SJIA 65 Tindamax R 65 bacteremic 65 hyperbilirubinemia 65 hepatitis C genotype 65 Mg Uk 65 asthenia fatigue 65 anagrelide 65 AZT zidovudine Retrovir 65 concomitant medications 65 MGd 65 vaccine serotypes 65 BI/NAP#/# 65 cryptococcal meningitis 65 non valvular atrial 65 low dose Iluvien 65 GLIADEL R Wafer 65 superficial basal cell carcinomas 65 bone marrow suppression 65 underwent CABG 65 eosinophilic pneumonia 65 Stent thrombosis 65 venlafaxine XR 65 Crohn Disease Activity 65 coronary stenosis 65 Human papillomavirus 65 underwent surgical resection 65 APTIVUS r 65 urticaria hives 65 BRSV 65 severe hepatomegaly 65 T1c 65 cEVR 65 hepatic enzymes 65 Clinically significant 65 pyelonephritis 65 International Prognostic Scoring 65 thrombotic complications 65 inhospital 65 flutamide 65 INVEGA ® 65 docetaxel Taxotere ® 65 hemorrhagic complications 65 Nilotinib 65 teriflunomide 65 CIMZIA TM 65 neuroendocrine cancers 65 EDSS scores 65 gastrointestinal GI perforation 65 nonvertebral fractures 65 bacteremic pneumonia 65 Doxil ® 65 Pharmacokinetics PK 65 tacrolimus ointment 65 PLX STROKE targeting 65 postoperative pulmonary 65 pulmonary resection 65 peginterferon alfa 2a Pegasys 65 coagulation disorders 65 Pneumocystis carinii pneumonia 65 pulmonary infiltrates 65 CIN3 + 65 mcg albinterferon alfa 2b 65 anastomotic leak 65 endophthalmitis 65 protease inhibitor PI 65 paresthesias 65 ceftriaxone 65 imiquimod cream 65 MRSA isolates 65 renal cell carcinomas 65 cisplatin vinorelbine 65 receiving FUSILEV 65 PASI scores 65 Dementia Related Psychosis 65 pooled comparator 65 saline placebo 65 Asymptomatic 65 autoimmune thyroid 65 pheochromocytoma 65 precancerous cervical lesions 65 Follicular Lymphoma 65 lung esophageal 65 relapsing remitting MS RRMS 65 vaginal candidiasis 65 Lactic acidosis 65 constipation nausea 65 linezolid resistant 65 etanercept Enbrel 65 AA Amyloidosis 65 completely resected 65 reflux disease GERD 65 glomerular filtration 65 MRSA colonization 65 ATACAND 65 BRCA1 mutation carriers 65 clinically evaluable patients 65 Systemic Lupus Erythematosus SLE 65 cisplatin chemotherapy 65 vesicoureteral reflux VUR 65 dysmenorrhoea 65 refractory gout 65 tumor lysis syndrome 65 cutaneous melanoma 65 Hepatocellular Carcinoma HCC 65 Adjuvant chemotherapy 65 PegIFN RBV 65 Pulmonary Embolism PE 65 thromboembolic 65 clinically asymptomatic 65 fallopian tube carcinoma 65 diarrhea nausea vomiting 65 Hepatotoxicity 65 ® lenalidomide 65 HBeAg positive 65 lichen planus 65 thrombotic thrombocytopenic purpura TTP 65 leukemia ALL 65 Fludara 65 Adverse events 65 interferon beta therapy 65 gastrointestinal GI motility disorders 65 Bronchiectasis 65 locoregional 65 thetreatment 65 urothelial carcinoma 65 Non inferiority 65 MDS MPD 65 x ULN 65 hypervascular tumors 65 biliary tract cancer 65 Acute Myeloid Leukaemia AML 65 torsade de pointes 65 Juvenile Idiopathic Arthritis 65 corticosteroid dose 65 mg TID 64 erythematosus 64 DEFLUX 64 Alphanate R 64 ASCUS 64 papillary carcinoma 64 acute GvHD 64 Partial Response 64 oesophagitis 64 cinacalcet 64 Zorbtive TM 64 GH deficiency 64 gastric adenocarcinoma 64 CMV disease 64 dengue hemorrhagic fever DHF 64 PREZISTA ritonavir 64 icatibant 64 aspartate aminotransferase AST 64 patients undergoing CABG 64 Psoriasis Area 64 LymphoStat B belimumab 64 pancreatic resection 64 obstructive coronary artery 64 primary immunodeficiency PI 64 adenomatous 64 KETEK 64 syncope fainting 64 anaphylactoid reactions 64 anemia thrombocytopenia 64 Human papilloma virus 64 gemcitabine carboplatin 64 idiopathic thrombocytopenic purpura 64 ocular toxicity 64 peritumoral brain edema 64 preterm newborns 64 humanized interleukin 6 64 haemolytic uraemic syndrome 64 metastatic malignant melanoma 64 pulmonary embolus 64 clevidipine 64 baseline LDH 64 ACE Inhibitors 64 herpetic keratitis 64 hypercholesterolaemia 64 recurrent bladder 64 nevirapine Viramune 64 insulin glulisine 64 carotid stenosis 64 Dacogen decitabine 64 chronic periodontitis 64 Valopicitabine 64 R Saizen R 64 Vidaza ® 64 lipid lowering agents 64 intravenous vancomycin 64 β blockers 64 reinfarction 64 visceral metastases 64 intraperitoneally 64 haloperidol Haldol 64 acellular pertussis DTaP 64 moderate hepatic impairment 64 nonmetastatic 64 retinal vein occlusion induced 64 anaplastic astrocytomas 64 finasteride Proscar 64 experienced virologic failure 64 benazepril 64 peginterferon alfa 64 hepatocellular carcinomas 64 advanced hepatocellular carcinoma 64 Bacillus Calmette Guerin BCG 64 intravesical therapy 64 IIIa inhibitors 64 BoNTA 64 HCV RESPOND 2 64 #mg/day [001] 64 genital herpes infections 64 nasopharyngitis headache 64 SCIg 64 interstitial brachytherapy 64 acne vulgaris 64 minimally symptomatic 64 cephalosporin antibiotics 64 pneumonia urinary tract 64 Venous thromboembolism 64 cytogenetic responses 64 Cimzia TM 64 tipranavir ritonavir 64 recurrent acute pancreatitis 64 Paraplatin ® 64 intravitreal injections 64 Leukemias 64 aplastic anemia AA 64 testicular tumors 64 hematopoietic cancers 64 NAVISTAR R 64 beta lactam antibiotic 64 REMICADE ® 64 tuberculin skin testing 64 nitrofurantoin 64 infection sinusitis 64 FDG PET imaging 64 Eraxis 64 im peramivir 64 Interferon alfa 64 Captopril 64 FUSILEV enhances 64 microgram kg 64 cervicitis 64 peginterferon alpha 2a 64 ARB telmisartan 64 antibiotics metronidazole 64 HES CEL 64 chronic myeloid 64 genital human papillomavirus 64 PROCRIT ® 64 cSSSIs 64 Acute myeloid leukemia 64 metastatic renal 64 Adjunctive 64 TORISEL 64 ULORIC 64 paclitaxel cisplatin 64 mcg linaclotide 64 fluvastatin 64 nausea vomiting headache 64 FOLFOX6 64 Progressive Multifocal Leukoencephalopathy 64 situ CIS 64 alpha1 antitrypsin deficiency 64 postoperative nausea 64 Renal dysfunction 64 immunocompetent 64 empyema 64 HSCT 64 radioiodine therapy 64 primidone 64 aseptic meningitis 64 venous thromboembolic events 64 nondiabetic patients 64 pancreatic prostate 64 Chronic HCV 64 aripiprazole Abilify 64 COPEGUS therapy 64 TMS Therapy 64 catheter occlusion 64 juvenile idiopathic arthritis 64 rituximab Rituxan 64 recurrent glioma 64 anti JCV antibodies 64 Idiopathic Pulmonary Fibrosis 64 Hypomagnesemia occurred 64 bovine thrombin 64 syncopal episodes 64 mg kg Hematide 64 % CI #.#-#.# [005] 64 amphotericin B 64 PEGINTRON TM 64 non hematological toxicities 64 lenalidomide dexamethasone 64 IXEMPRA 64 primary hyperparathyroidism 64 rizatriptan 64 variceal hemorrhage 64 treat chronic sinusitis 64 patients receiving ERBITUX 64 COMBIVIR 64 Betaferon R 64 vesicoureteral reflux 64 erythema redness 64 serogroup B 64 colorectal carcinomas 64 Skin rashes 64 VELCADE melphalan 64 squamous cell carcinoma SCC 64 Navelbine ® 64 FluCAM 64 chronic HBV 64 AVONEX ® 64 Kinoid 64 sustained ventricular tachycardia 64 malignancy HCM 64 somnolence fatigue 64 chemotherapy induced neutropenia 64 PHPT 64 paroxetine Paxil 64 bone marrow reticulin deposition 64 neutropenic 64 bacteriuria 64 Adefovir 64 Adhibit 64 noncardiac 64 hypertrophic scars 64 SinuNase TM 64 basal bolus regimen 64 pretransplant 64 methicillin sensitive 64 linaclotide treated 64 bacteremia 64 treat benign prostatic 64 basiliximab 64 cytogenetic response 64 rheumatoid arthritis osteoarthritis ankylosing 64 Aortic stenosis 64 Hurthle cell 64 adverse reactions incidence 64 TNF Tumor Necrosis Factor 64 acute coronary syndromes ACS 64 underwent coronary angiography 64 CIN2 64 fosamprenavir 64 cardiovascular cerebrovascular 64 colorectal neoplasms 64 leukoencephalopathy 64 nodal metastasis 64 NSAID induced 64 Common Toxicity Criteria 64 FRAGMIN 64 polycythemia vera essential thrombocythemia 64 TPV r 64 gastrointestinal hemorrhage 64 quadrivalent 64 tapentadol IR 64 differentiated thyroid 64 Community Acquired Pneumonia 64 antimicrobial prophylaxis 64 reduce serum phosphate 64 DVT PE 64 Pegylated interferon 64 R adefovir dipivoxil 64 liver decompensation 64 poor metabolizers 64 BR.# 64 Arch Intern Med 64 tolterodine ER 64 hypercalcemia 64 perioperatively 64 NOMID 64 CMV reactivation 64 variceal bleeding 64 galiximab 64 adverse reactions ≥ 64 intraventricular hemorrhage 64 posaconazole 64 DLTs 64 nonhematologic adverse reactions 64 Investigational Treatment 64 nucleoside naive 64 seroconverted 64 reteplase 64 nasopharyngitis upper 64 symptomatic benign prostatic 64 postoperative morbidity 64 invasive ductal 64 hemodynamically significant 64 receiving immunosuppressive therapy 64 % Confidence Interval 64 ritonavir boosted atazanavir 64 Xelox 64 intravesical infusion therapy 64 cholelithiasis 64 moderate renal impairment 64 Vitrasert R 64 gastric carcinoma 64 CYT# potent vascular disrupting 64 sarcomatoid 64 ACR# ACR# 64 calcineurin inhibitors 64 neonatal sepsis 64 RAPAFLO R 64 chronically immunosuppressed solid 64 dexamethasone intravitreal implant 64 Camptosar ® 64 Velcade bortezomib 64 acute rhinosinusitis 64 node metastases 64 MULTAQ 64 Gemzar ® 64 Streptococcus pyogenes 64 Staphylococcus aureus MRSA 64 naïve HCV 64 invasive fungal infections 64 IFN alfa 64 Percutaneous vertebroplasty 64 astrocytomas 64 neutrophil counts 64 ICD shocks 64 LRTI 64 unfractionated heparin UFH 64 shingles herpes zoster 64 unfavorable cytogenetics 64 IMiDs ® compound 64 toenail onychomycosis 64 plasma creatinine 64 PEG INTRON R